The Japan Diagnostic Imaging Services Market Report is Segmented by Modality (MRI, CT, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications), Service Provider (Hospitals, Diagnostic Imaging Centers, Clinics and Specialty Centers, Others). The Market Forecasts are Provided in Terms of Value (USD).

The size of the Japan Medical Imaging Market market was valued at USD 563.56 million in 2023 and is projected to reach USD 841.81 million by 2032, with an expected CAGR of 5.9 % during the forecast period. Recent developments include: In November 2023, Canon Inc., and Cleveland Clinic announced a partnership agreement. The strategy is aimed to create innovative IT solutions for healthcare and imaging with the objective to enhance patient outcomes, treatment, and diagnosis and to create a comprehensive center for imaging research. , In November 2023, RapidAI, a health technology firm specializing in image analysis software, obtained a Class III Shonin authorization in Japan and initiated a hybrid technology program. The new platform provides non-contrast CT offering, and rapid edge cloud for stroke detection. , In July 2023, FUJILFILM Corp., declared to restructure its Medical System companies’ group, Japan indulge in the medical system dealings built on their operational responsibilities, such as sales & maintenance, R& D, and corporate strategy services. The restructuring is estimated to be finished by 2024. , In July 2023, Canon Medical Systems Corp. declared that it has acquired the Resonac Corporation. The agreement is aimed to acquire Minaris Medical America, Inc., Resonac subsidiaries Minaric Medical Co., Ltd. Following this share acquisition, Minaris Medical, which runs companies dealing with automated analytical tools and in vitro diagnostic reagents, may amalgamate under Canon Medical. , In April 2023, Astellas Pharma Inc. declared that it has acquired complete share of Iveric bio, Inc. The acquisition was done through Berry Merger Sub, Inc., a wholly owned subsidiary of Astellas US Holding, Inc., as it agreed to acquire all of the outstanding shares of Iveric Bio. As per the agreement Astellas is going to receive the entire regulation of Iveric Bio. , In April 2023, Nikon introduced ECLIPSE Ui, a digital imaging microscope which is Japan’s first microscope for medical uses. ECLIPSE Ui offers exclusive design without an eye piece lens including in the microscope. a model which enhances the diagnostician’s opinion posture and permits the observation images sharing on the display. , In December 2021, Taiyo Pharma Tech & GE Healthcare Pharma announced that they have entered into an agreement to produce “Contrast Media” applied for image diagnosing. .

Japan Diagnostic Imaging Market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027. Japan Diagnostic Imaging Market - Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2023-2027 By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions, Mammography, Others), By Mobility, By Source, By Application, By End User, By Region, Competition Forecast & Opportunities, FY2027

The Japan Diagnostic Imaging Equipment Market Report is Segmented by Modality (X-Ray, MRI, Ultrasound, Computed Tomography, Nuclear Imaging, Mammography and Other Modalities), Portability (Fixed Systems and Mobile and Hand-Held Systems), Application (Cardiology, Oncology, Neurology, and More), and End-User (Hospitals, Diagnostic Imaging Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).

USD 959.38 Million in 2024; projected USD 1410.22 Million by 2033; CAGR 4.38%.

The size of the Japan Medical Imaging Services Industry market was valued at USD XX Million in 2024 and is projected to reach USD XXX Million by 2033, with an expected CAGR of 6.28% during the forecast period. Recent developments include: In June 2022, Konica Minolta, Inc. released DDRAtlas Ver. 1.0, which records normal cases, as the first part of Dynamic Digital Radiography DDRAtlas on its membership website in Japan., In April 2022, Clairvo Technologies obtained market authorization for VIDA Insights, an image analysis software to assist in the reading of chest CT images developed by VIDA Diagnostics Inc. in accordance with the Pharmaceutical and Medical Device Act.. Key drivers for this market are: Increasing geriatric poulation, Increased adoption of diagnostic imaging by the medical industry; Technological advances and rapid innovation; Increased incidence of chronic diseases. Potential restraints include: Expensive procedures and equipment, Side effects of diagnostic imaging procedures. Notable trends are: Oncology Segment is expected to Account for Largest Market Share during the Forecast Period.

Japan Diagnostic Imaging Services Market size was valued at USD 1.5 Billion in 2023 and is projected to reach USD 2.6 Billion by 2031 growing at a CAGR of 5.6% from 2024 to 2031.

Japan Diagnostic Imaging Services Market Dynamics

The key market dynamics that are shaping the Japan diagnostic imaging services market include:

Key Market Drivers

Aging Population and Increasing Healthcare Demand: According to the Japanese Ministry of Internal Affairs and Communications, Japan have the world's greatest proportion of elderly people, with more than 29% of individuals 65 and older as of 2022. The National Health Insurance Association states that medical imaging operations for the elderly have climbed by 38% in the last five years.

Discover the booming Japanese Computed Tomography (CT) market! This comprehensive analysis reveals key trends, growth drivers, and leading players shaping the future of medical imaging in Japan. Explore market size projections, segmentation data, and forecast insights for 2025-2033. Recent developments include: April 2023: Canon Inc. announced that Canon and the National Cancer Center Japan (NCC) have begun clinical research employing a next-generation X-ray CT system with photon-counting computed tomography (photon-counting CT, PCCT)., April 2022: Fujitsu and the Southern Tohoku General Hospital announced the launch of a joint research project with Fujitsu Japan Limited and FCOM CORPORATION on AI technology for the early detection of pancreatic cancer from computed tomography (CT) scans without contrast agent (non-contrast CT scans).. Key drivers for this market are: Increasing Geriatric Population and Chronic Disease Burden, Technological Advancements in Computed Tomography. Potential restraints include: Increasing Geriatric Population and Chronic Disease Burden, Technological Advancements in Computed Tomography. Notable trends are: The Diagnostic Centers Segment is Expected to Witness Significant Growth in End Users.

Snapshot img

Medical Imaging Market Size 2025-2029

The medical imaging market size is valued to increase by USD 15.2 billion, at a CAGR of 6% from 2024 to 2029. Increasing prevalence of chronic conditions will drive the medical imaging market.

Market Insights

Europe dominated the market and accounted for a 37% growth during the 2025-2029.
By End-user - Hospitals segment was valued at USD 15.30 billion in 2023
By Product - X-ray imaging segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 74.64 billion 
Market Future Opportunities 2024: USD 15.20 billion
CAGR from 2024 to 2029 : 6%

Market Summary

Medical imaging, a critical component of modern healthcare, involves the use of various imaging technologies to produce visual representations of the interior of the body. The market is driven by several factors, including the increasing prevalence of chronic conditions and an aging population. These factors have led to a higher demand for diagnostic imaging procedures to facilitate early and accurate disease detection and treatment. Another significant trend in the medical imaging industry is the integration of artificial intelligence (AI) and machine learning algorithms. This technology is revolutionizing the field by improving diagnostic accuracy, reducing the need for human intervention, and streamlining workflows. For instance, AI-powered systems can analyze medical images and identify patterns indicative of diseases, enabling faster and more accurate diagnoses. Despite these advancements, medical imaging remains an expensive endeavor. High costs associated with imaging equipment, maintenance, and personnel contribute to the financial burden. To address this challenge, healthcare providers are exploring various strategies, such as supply chain optimization and outsourcing imaging services to specialized centers. This approach not only reduces costs but also enhances operational efficiency and ensures access to advanced imaging technologies. In summary, the market is experiencing significant growth due to the increasing prevalence of chronic conditions and the integration of AI. However, the high costs associated with medical imaging continue to pose a challenge. Healthcare providers are addressing this issue by implementing cost-saving strategies while maintaining diagnostic accuracy and operational efficiency.

What will be the size of the Medical Imaging Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free SampleThe market is a dynamic and ever-evolving sector, driven by advancements in technology and the growing demand for accurate and efficient diagnostic tools. One significant trend shaping this industry is the integration of advanced data analytics platforms into medical imaging systems. These platforms employ feature extraction methods, image enhancement algorithms, and data mining techniques to streamline clinical decision-making processes. For instance, image annotation tools enable more precise MRI sequence optimization, while X-ray imaging systems benefit from CT scan protocols and image classification methods. Furthermore, image visualization techniques and analysis software facilitate faster and more accurate diagnosis. Ultrasound transducer technology, PET scanner technology, and image filtering techniques also contribute to improved image quality assessment. These advancements have the potential to revolutionize healthcare, enabling remote diagnostics and object detection algorithms for earlier and more accurate disease detection. Additionally, augmented reality applications, virtual reality applications, cloud-based storage, and telemedicine platforms are transforming the way medical professionals access and interpret imaging data, ultimately leading to better patient outcomes.

Unpacking the Medical Imaging Market Landscape

In the dynamic the market, machine learning models and deep learning algorithms are revolutionizing clinical workflow optimization. According to industry reports, the implementation of these advanced technologies has led to a 30% increase in diagnostic accuracy and a 25% reduction in radiologist reading time. Network infrastructure and PACS system integration are crucial for seamless data transfer and accessibility, enabling quantitative image analysis and computer-aided detection.

Image standardization protocols and noise reduction techniques ensure consistent image quality and enhance diagnostic precision. Radiation dose reduction is another significant concern, with a 50% decrease in radiation exposure reported through the use of modern diagnostic imaging modalities and image-guided interventions. Artifact correction methods, image segmentation techniques, and biomedical signal processing further improve image quality metrics and data security protocols.

Functional ima

The Japan MRI Market Report is Segmented by Architecture (Closed MRI Systems, Open MRI Systems), Field Strength (Low-Field (<1 T), High-Field (1. 5 T), Very High-Field (3 T), Ultra-High-Field (7 T)), Application (Neurology, Oncology, Cardiology, Musculoskeletal, Abdominal & Pelvic, Pediatric Imaging), End User (Hospitals, Stand-Alone Imaging Centers, Others). The Market Forecasts are Provided in Terms of Value (USD).

The Japan Nuclear Imaging Market Report is Segmented by Product (Equipment: PET/CT Scanners, SPECT/CT Scanners, PET/MRI Scanners; Radioisotopes: SPECT and PET Radioisotopes), Application (Cardiology, Neurology, Thyroid, Oncology, Other Applications), and End User (Hospitals, Diagnostic Imaging Centres, Academic & Research Institutes). The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Refurbished Medical Imaging Equipment Market Size 2025-2029

The refurbished medical imaging equipment market size is forecast to increase by USD 7.68 billion, at a CAGR of 8.5% between 2024 and 2029.

The market is driven by the increasing demand for cost-effective and efficient medical imaging devices. As healthcare costs continue to rise, the affordability of refurbished equipment becomes an attractive option for healthcare providers. Furthermore, the adoption of eco-friendly practices in the healthcare industry is fueling the market's growth, as refurbished equipment offers a sustainable solution to reducing the environmental impact of medical waste. However, the market faces challenges, including the negative perception of end-users about refurbished medical equipment. Some healthcare providers may view refurbished equipment as less reliable or less advanced than new equipment. Addressing these concerns through certification programs and ensuring the highest quality standards can help alleviate these concerns and expand the market's reach. Companies seeking to capitalize on market opportunities should focus on providing top-notch customer service, offering flexible financing options, and ensuring the highest quality standards for their refurbished medical imaging equipment. By addressing the challenges and leveraging the market's drivers, companies can effectively navigate the competitive landscape and capture a significant share of the market.

What will be the Size of the Refurbished Medical Imaging Equipment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market continues to evolve, driven by the ever-changing dynamics of technology and healthcare sector requirements. MRI machines, CT scanners, and X-ray systems are continually upgraded to enhance image quality and enable advanced applications such as precision medicine, image registration, and personalized medicine. Efficiency improvements are a key focus, with equipment financing, quality assurance, and asset management solutions facilitating cost optimization and seamless hospital workflow. CE marking and regulatory compliance ensure the safe and effective use of refurbished imaging equipment. Advancements in medical imaging technology, including 3D imaging, image segmentation, and image analysis, are revolutionizing disease diagnosis and interventional radiology. Big data analytics and artificial intelligence (AI) are increasingly integrated into medical imaging software for early detection and treatment planning. Emerging technologies like image fusion, contrast agents, noise reduction, and machine learning are transforming the industry, offering significant benefits in terms of spatial resolution, contrast resolution, and diagnostic accuracy. Preventive screening and patient monitoring are also gaining importance, with remote diagnostics and real-time image interpretation becoming essential components of the healthcare ecosystem. The ongoing adoption of technology in healthcare is leading to the obsolescence of traditional imaging systems. Maintenance and repair services, along with upgrade options, are crucial for extending the life cycle of refurbished medical imaging equipment. In the realm of cardiovascular imaging, advancements in image acquisition, image processing, and image optimization are enabling more accurate and timely diagnosis. Radiation shielding and image interpretation tools are also essential for ensuring the safety and effectiveness of diagnostic imaging. The integration of medical imaging with healthcare informatics, DICOM standards, and cloud computing is streamlining the management and sharing of medical images, making them more accessible and valuable for clinical trials and research purposes. In conclusion, the market is a dynamic and evolving landscape, characterized by continuous innovation and adaptation to the changing needs of the healthcare sector. From image acquisition and processing to diagnostic accuracy and patient care, refurbished medical imaging equipment plays a crucial role in enhancing the quality and accessibility of healthcare services.

How is this Refurbished Medical Imaging Equipment Industry segmented?

The refurbished medical imaging equipment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductX-ray imagingUltrasound systemsMRICT scanner imagingSPECT/ PET scannersEnd-userHospitalsDiagnostic centersApplicationCardiovascularOncologyOrthopedicsGynecologyOthersGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAPACChinaIndiaJapanSouth AmericaBrazilRest of World (ROW).

By Product Insights

The x-ray imaging segment is estim

The Japanese digital X-ray market, a segment of the global market valued at $560.84 million in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 9.54%, presents significant opportunities for growth. Driven by factors such as an aging population requiring increased diagnostic imaging, rising prevalence of chronic diseases like cancer and cardiovascular ailments necessitating frequent X-rays, and government initiatives promoting healthcare infrastructure modernization, the market is poised for expansion. Technological advancements, such as the adoption of direct radiography offering superior image quality and faster scan times compared to computed radiography, further fuel this growth. While the availability of advanced imaging technologies like MRI and CT scans may pose some restraint, the relative affordability and accessibility of digital X-ray systems, particularly portable units for remote areas and specialized applications, ensure sustained demand. Within Japan's market, the orthopedic and oncology segments are expected to be particularly robust, driven by high incidence rates of related diseases and a large aging population. Hospitals and diagnostic centers constitute the major end-users, though the increasing prevalence of mobile clinics and telemedicine may broaden the end-user segment in the coming years. Key players like Fujifilm Holdings Corporation, Canon Medical Systems Corporation, and Shimadzu Corporation, with their established presence and technological capabilities, will continue to dominate, while smaller players might focus on niche applications and regions. Growth within the Japanese market will largely depend on government healthcare spending, technological innovation focused on AI-powered image analysis for improved diagnostic accuracy and efficiency, and the expansion of medical tourism. Factors such as stringent regulatory approvals, potential price sensitivity among consumers, and the need for skilled personnel to operate and interpret X-ray images may pose challenges. However, the overall trajectory suggests a positive growth outlook for the foreseeable future. The market segmentation analysis reveals strong potential in portable systems for enhanced accessibility and direct radiography technology for improved efficiency and image quality. These factors, coupled with the projected growth rate, indicate a robust investment potential in this sector. Analyzing the regional performance within Japan could offer further opportunities for targeted investment strategies. Recent developments include: April 2023: Canon Inc., Canon Medical Systems Corporation (Canon Medical), and the National Cancer Center Japan (NCC) have begun clinical research employing a next-generation X-ray CT system with photon-counting computed tomography (photon-counting CT, PCCT)., June 2022: Konica Minolta, Inc. released DDRAtlas Ver. 1.0, which records normal cases, as the first part of Dynamic Digital Radiography DDRAtlas on its membership website in Japan. With the help of a DDR system that can record dynamic images utilizing a standard X-ray system, Konica Minolta has been attempting to provide new diagnostic values in Japan.. Key drivers for this market are: Increasing Prevalence of Chronic Diseases, Increasing Technological Advancements. Potential restraints include: Increasing Prevalence of Chronic Diseases, Increasing Technological Advancements. Notable trends are: Cancer Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

Japanese company Hitachi accounted for three percent of the world's market for diagnostic imaging in 2017. By 2024, this share is expected to decrease to 2.7 percent. Diagnostic imaging allows medical examiners to observe the inside of a body to establish a medical condition. Different techniques and machines allow radiologists and other health professionals to take a picture of the structures and activities occurring in the body. The best-known types of diagnostic imaging are radiography (X-rays), ultrasound, computed tomography (CT), and magnet resonance imaging (MRI). The global top 3 companies The global diagnostic imaging market is dominated by three companies which are all expected to maintain a share of about 20 or more percent until 2024. These three companies are German Siemens (Healthineers), U.S.-based General Electric Healthcare, and Philips from the Netherlands. The total global diagnostic imaging market currently is estimated at around 40 billion U.S. dollars. One of the main drivers for the market is the growing demand for early stage diagnoses of chronic diseases of an increasingly aging population, especially in developed countries. The importance of medical imaging Today, medical diagnosis without diagnostic imaging is hardly imaginable. It makes it possible to take a detailed image of the human body and his structures, thus allowing an exact diagnosis and to choose the most appropriate treatment. Although most types of diagnostic imaging are painless, some require a patient to remain still for an extended period inside a machine, which causes problems for some patients, i.e. claustrophobia. Other methods could involve exposure to some radiation or being anesthetized. The fact that there are, for example, annually 35-40 million MRI scans in the United States alone, shows the massive impact and importance of medical imaging in today’s health care.

The Japan nuclear imaging devices market, valued at $325.42 million in 2025, is projected to experience steady growth, driven by a rising geriatric population necessitating increased diagnostic procedures and technological advancements leading to improved image quality and faster scan times. The market's Compound Annual Growth Rate (CAGR) of 4.55% from 2025 to 2033 indicates a consistent expansion. Growth is fueled by the increasing prevalence of cardiovascular diseases, cancer, and neurological disorders, all of which benefit significantly from accurate and timely nuclear imaging diagnostics. Furthermore, government initiatives promoting healthcare infrastructure development and increased investment in advanced medical technologies are contributing factors. The segments within the market – equipment (SPECT and PET scanners, radioisotope production facilities) and radioisotopes (Technetium-99m, Fluorine-18, etc.) – are expected to witness parallel expansion, with PET radioisotopes potentially experiencing faster growth due to the rising demand for oncology diagnostics. Competition among established players like GE Healthcare, Siemens Healthineers, and Fujifilm, coupled with the emergence of innovative technologies, will shape market dynamics in the coming years. While potential restraints could include regulatory hurdles and cost considerations related to advanced equipment and radioisotopes, the overall market outlook remains positive due to the aforementioned growth drivers. The market segmentation further highlights the significant roles of specific applications. SPECT applications, predominantly in cardiology and orthopedics, maintain a substantial share, reflecting the continued importance of these procedures. However, PET applications, particularly in oncology, are poised for accelerated growth due to increasing cancer incidence rates and the superior diagnostic capabilities of PET scans in detecting and staging various types of cancers. The presence of key players like ATOX Co. Ltd, Bracco Imaging, and Canon indicates a competitive landscape characterized by continuous innovation and a focus on meeting evolving clinical needs. The market's trajectory suggests a robust future, especially with the continued technological advancements and increasing healthcare expenditure in Japan. Recent developments include: Oct 2022: The IAEA redesignated National Institutes for Quantum Science and Technology (QST) as a Collaborating Centre until 2026 for radiation oncology, nuclear medicine and molecular imaging, dosimetry, and science technology and society., Aug 2022: PeptiDream Inc., a Japan-based biopharmaceutical company, expanded its strategic partnership with RayzeBio Inc. to discover and develop peptide-radioisotope (RI) conjugates for use as radiopharmaceutical therapeutics. Under the terms of the agreement, RayzeBio grants PeptiDream an option to attain development and commercialization rights in Japan for the joint peptide-RI programs., Jan 2021: Fuzionaire Radioisotope Technologies K.K. entered into a feasibility study agreement with Nihon Medi-Physics Co. Ltd, a Japan-based radiopharmaceutical company, to develop and commercialize Fuzionaire Dx's radiopharmaceutical technologies in Japan.. Key drivers for this market are: Rise in Prevalence of Cancer and Cardiac Disorders, Increase in Technological Advancements; Growth in the Applications of Nuclear Medicine and Imaging. Potential restraints include: Rise in Prevalence of Cancer and Cardiac Disorders, Increase in Technological Advancements; Growth in the Applications of Nuclear Medicine and Imaging. Notable trends are: Oncology Segment is Expected to Witness Significant Growth Over the Forecast Period.

3D Medical Imaging Market Outlook

According to our latest research, the Global 3D Medical Imaging market size was valued at $23.8 billion in 2024 and is projected to reach $48.6 billion by 2033, expanding at a CAGR of 8.2% during the forecast period of 2025–2033. This robust growth is primarily driven by the increasing adoption of advanced diagnostic imaging technologies that enable earlier and more accurate disease detection, particularly in oncology and cardiology. The integration of artificial intelligence and machine learning with 3D imaging platforms has further accelerated the market, allowing for enhanced image reconstruction, improved workflow automation, and better clinical outcomes. As healthcare providers continue to prioritize precision medicine and minimally invasive procedures, the demand for innovative 3D medical imaging solutions is expected to surge globally.

Regional Outlook

North America currently commands the largest share of the 3D medical imaging market, accounting for over 36% of global revenue in 2024. The region’s dominance is attributed to its mature healthcare infrastructure, substantial investments in research and development, and the widespread availability of advanced imaging modalities across hospitals and diagnostic centers. The presence of leading industry players, strong reimbursement frameworks, and a high prevalence of chronic diseases such as cancer and cardiovascular conditions have further cemented North America’s leadership. Regulatory support from agencies like the FDA, coupled with a robust pipeline of innovative imaging products, continues to drive market expansion. Additionally, the region’s early adoption of artificial intelligence and cloud-based imaging solutions has significantly improved diagnostic accuracy and operational efficiency, further fueling growth.

The Asia Pacific region is emerging as the fastest-growing market for 3D medical imaging, projected to register a CAGR of 11.3% between 2025 and 2033. This rapid growth is propelled by increasing healthcare expenditure, rising awareness about early disease diagnosis, and expanding access to modern healthcare facilities in countries such as China, India, and Japan. Government initiatives to modernize healthcare infrastructure and promote digital health transformation have attracted significant investments from both domestic and international stakeholders. The proliferation of private diagnostic centers, coupled with the rising burden of lifestyle-related diseases, has intensified the demand for 3D imaging solutions. Furthermore, partnerships between global imaging giants and local technology firms are accelerating the deployment of cost-effective and scalable imaging systems tailored to the unique needs of the Asia Pacific market.

Emerging economies in Latin America and the Middle East & Africa are witnessing gradual adoption of 3D medical imaging technologies, albeit with notable challenges. While urban centers in Brazil, Mexico, and South Africa have begun integrating advanced imaging modalities, rural and underdeveloped regions continue to face barriers such as limited healthcare budgets, inadequate infrastructure, and a shortage of skilled radiologists. Policy reforms aimed at universal healthcare coverage and public-private partnerships are gradually improving access to diagnostic imaging. However, high equipment costs, regulatory complexities, and the need for localized solutions remain key hurdles. Despite these challenges, the growing incidence of chronic diseases and the increasing focus on medical tourism are expected to drive incremental demand for 3D medical imaging in these regions over the next decade.

Report Scope

Europe Diagnostic Imaging Market Outlook 2031:

The Europe diagnostic imaging market size was valued at USD 9.18 Billion in 2022 and is projected to reach USD 16.46 Billion by 2031, expanding at a CAGR of 6.7% during the forecast period 2023 - 2031. Growth of the market is attributed to the development of advanced devices, rising healthcare expenditure, increasing government initiatives, and growing cases of injuries & accidents.

Imaging equipment like ultrasound and radiographic machines contains research support programs. Magnetic resonance imaging (MRI), x-rays, and computed tomography (CT) scans are additional equipment’s that are used as human research apparatuses.



The Covid-19 pandemic affected the demand and supply of Europe diagnostic imaging market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Diagnostic Imaging Market Trends, Drivers, Restraints, and Opportunities

• Increase in outpatient surgeries is projected to boost the market in the coming years.


• Rise in minimally invasive surgical procedures is major factor fueling the market during forecast period.


• High cost of diagnostic imaging equipment is anticipated to hamper market growth.


• <span style="font-size:12.0pt"&g

Snapshot img

AI In MRI Market Size 2025-2029

The AI in MRI market size is valued to increase by USD 1.03 billion, at a CAGR of 27.8% from 2024 to 2029. Increasing pressure on radiology departments and workforce shortages will drive the ai in mri market.

Major Market Trends & Insights

North America dominated the market and accounted for a 43% growth during the forecast period.
By Component - Software segment was valued at USD 42.00 billion in 2023
By End-user - Hospitals segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 1.00 million
Market Future Opportunities: USD 1026.30 million
CAGR from 2024 to 2029 : 27.8%

Market Summary

The market experiences significant growth, driven by the increasing demand for efficient and accurate diagnostic solutions in radiology. Integrated AI platforms and digital marketplaces are gaining traction, streamlining workflows and enhancing diagnostic capabilities. This development signifies a significant shift towards advanced technological solutions and digital commerce. However, challenges persist, including data quality concerns and ensuring generalizability and privacy. According to recent market intelligence, The market is projected to reach a value of USD3.5 billion by 2025, underscoring its potential impact on healthcare.
As radiology departments face mounting pressure due to workforce shortages, AI-powered MRI systems offer a promising solution to improve diagnostic accuracy and efficiency. Despite these advancements, addressing data quality and privacy concerns remains crucial to ensure widespread adoption and trust in this evolving technology.

What will be the Size of the AI In MRI Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the AI In MRI Market Segmented ?

The ai in mri industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Software
  Services
  Hardware


End-user

  Hospitals
  Diagnostic imaging centers
  Others


Application

  Neurology
  Musculoskeletal
  Cardiovascular
  Prostate
  Others


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    Japan


  South America

    Brazil


  Rest of World (ROW)

By Component Insights

The software segment is estimated to witness significant growth during the forecast period.

The market is experiencing continuous evolution, with software being a particularly dynamic and innovative segment. This intelligence layer unlocks clinical and operational value from imaging data, ranging from established medical imaging corporations to specialized AI startups. One sub-segment, AI algorithms for image reconstruction, uses deep learning to generate high-resolution images from under-sampled data, reducing scan times by up to 50% without compromising diagnostic quality. Another crucial software category is computer-aided detection and diagnosis, designed to assist radiologists by automatically identifying, segmenting, and characterizing potential abnormalities, such as tumors, lesions, or anatomical anomalies.

Request Free Sample

The Software segment was valued at USD 42.00 billion in 2019 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How AI In MRI Market Demand is Rising in North America Request Free Sample

The market is witnessing significant growth, with North America leading the charge. This region, primarily driven by the United States and Canada, accounts for the largest market share due to its advanced healthcare infrastructure, high per capita healthcare expenditure, and a culture that embraces technological innovation. The presence of key original equipment manufacturers (OEMs) and a thriving ecosystem of AI software startups in technology hubs further bolsters the region's dominance. The strong regulatory framework in place is another catalyst for market expansion.

According to recent reports, the North American market is projected to grow at a steady pace, surpassing USDX billion by 2027. Europe is expected to follow closely, fueled by advancements in healthcare technology and increasing demand for AI solutions in radiology. The Asia Pacific region is also gaining momentum, with countries like China and India investing heavily in healthcare technology and AI research.

Market Dynamics

Our researchers analyzed the

The global 3D medical imaging market size is projected to grow from USD 4.87 billion in 2025 to USD 8.13 billion by 2033, exhibiting a CAGR of 6.61%.
Report Scope:

The APAC Diagnostic Imaging Equipment Market report segments the industry into By Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications), By End-User (Hospital, Diagnostic Centers, Other End-Users), and Geography (China, Japan, India, Australia, South Korea, and more).